VISUAL COMMUNICATION BETWEEN MOBILE COMMUNICATION DEVICES AND DRUG DELIVERY DEVICES

• US 20170237486A1
• Filed: 02/11/2016
• Published: 08/17/2017
• Est. Priority Date: 02/11/2016
• Status: Abandoned Application

• Current Assignee: West Pharmaceutical Services Incorporated
• Original Assignee: West Pharmaceutical Services Incorporated
• Inventors: ESPOSITO, Anthony G.
• Application Number:
  US15/041,655
• Publication Number:
  US 20170237486A1
• Time in Patent Office: Days
• CPC Class Codes: G16H 20/17 delivered via infusion or injection
• CPC Class Codes: G16H 40/63 for local operation
• CPC Class Codes: G16H 40/67 for remote operation
• CPC Class Codes: H04B 10/116 Visible light communication

Abstract

Method and apparatus are directed to a visible light communication module configured to transmit information associated with a drug delivery device. The visible light communication module comprises a controller and a light source. The controller is configured to: receive information associated with the drug delivery device; and modulate, in accordance with the received information, at least one drive signal for driving the light source configured to emit visible light signals of a first wavelength. The light source is configured to emit the visible light signals in accordance with the modulated at least one drive signal.

Claims

1. A method for transmitting information associated with a drug delivery device, the method comprising:

receiving information associated with the drug delivery device;

modulating, in accordance with the received information, at least one drive signal for driving at least one light source configured to emit visible light signals of a first wavelength; and

emitting the visible light signals in accordance with the modulated at least one drive signal.

2. The method of claim 1, wherein the emitting further comprises transmitting the visible light signals to a computing device including an image sensor.

3. The method of claim 2, wherein the computing device is configured to convert the transmitted visible light signals into digital data associated with the drug delivery device.

4. The method of claim 1, wherein the at least one drive signal includes at least one drive voltage signal or at least one drive current signal.

5. The method of claim 1, wherein the received information comprises at least one of an identifier of the drug delivery device, a mode of operation of the drug delivery device, or an ambient temperature of the drug delivery device.

6. The method of claim 1, wherein the modulating comprises on-off keying.

7. The method of claim 1, wherein the modulating comprises modulating, in accordance with the received information, at least one drive signal for driving at least one light source configured to emit visible light signals of the first wavelength having the levels of the at least one light source changed between a peak level and a bottom level with different frequencies, different phases, or different amplitudes.

8. A method for transmitting information associated with a drug delivery device, the method comprising:

receiving information associated with the drug delivery device;

modulating, in accordance with the received information, a first, second, and third drive signals for driving first, second, and third light sources, respectively, the first light source being configured to emit first visible light signals of a first wavelength, the second light source being configured to emit second visible light signals of a second wavelength, and the third light source being configured to emit third visible light signals of a third wavelength, wherein the first wavelength is different than the second wavelength; and

emitting at least one of the first, second, or third visible light signals in accordance with the modulated first, second, or third drive signals.

9. The method of claim 8, further comprising, prior to the receiving information associated with the drug delivery device, actuating the drug delivery device.

10. 1 he method of claim 8, wherein each of the first, second, and third drive signals includes at least one drive voltage signal or at least one drive current signal.

11. The method of claim 8, wherein the received information comprises at least one of an identifier of the drug delivery device, a mode of operation of the drug delivery device, or an ambient temperature of the drug delivery device.

12. The method of claim 8, wherein the modulating further comprises independently modulating, in accordance with the received information, the first, second, and third drive signals for driving the first, second, and third light sources, respectively, the first light source being configured to emit first visible light signals of the first wavelength, the second light source being configured to emit second visible light signals of the second wavelength, and the third light source being configured to emit third visible light signals of the third wavelength, wherein the first wavelength is different than the second wavelength.

13. A visible communications module configured to transmit information associated with a drug delivery device, the visible communications module comprising:

a controller configured to;

receive information associated with the drug delivery device; and

modulate, in accordance with the received information, at least one drive signal for driving at least one light source configured to emit visible light signals of a first wavelength; and

at least one light source configured to emit the visible light signals in accordance with the modulated at least one drive signal.

14. The visible communications module of claim 13, wherein the at least one light source is further configured to emit to transmit the visible light signals to a computing device including an image sensor.

15. The visible communications module of claim 14, wherein the at least one drive signal includes at least one drive voltage signal or at least one drive current signal.

16. The visible communications module of claim 14, wherein the received information comprises at least one of an identifier of the drug delivery device, a mode of operation of the drug delivery device, or an ambient temperature of the drug delivery device.

17. The visible communications module of claim 14, wherein the controller is further configured to modulate the at least one drive signal via on-off keying.

18. The visible communications module of claim 14, further comprising a power source configured to provide power to the visible communications module.

19. The visible communications module of claim 18, wherein the power source is configured to provide power to the visible communications module in response to activation of the drug delivery device.

20. The visible communications module of claim 14, wherein the at least one light source includes a light emitting diode (LED).